TY  - BOOK
T1  - EpiPen price increases :how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY).
VL  - 114-805
CN  - Y 4.L 11/4:S.HRG.114-805
N1  - Shipping list no.: 2019-0162-M.
ID  - 1374406
KW  - Prescription pricing
KW  - Drugs
KW  - Pharmaceutical industry
KW  - Competition
KW  - Drug delivery devices
KW  - Competition.
KW  - Drugs
KW  - Pharmaceutical industry.
KW  - Prescription pricing.
TI  - EpiPen price increases :how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY).
LK  - https://purl.fdlp.gov/GPO/gpo113215
UR  - https://purl.fdlp.gov/GPO/gpo113215
ER  -